Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Depomed Inc (DEPO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 490,848
  • Shares Outstanding, K 63,010
  • Annual Sales, $ 455,900 K
  • Annual Income, $ -88,720 K
  • 36-Month Beta 1.29
  • Price/Sales 1.18
  • Price/Cash Flow 12.52
  • Price/Book 2.47

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.53 +3.19%
on 01/18/18
8.82 -11.90%
on 12/21/17
-0.88 (-10.17%)
since 12/19/17
3-Month
4.31 +80.28%
on 11/02/17
9.11 -14.71%
on 12/18/17
+2.34 (+43.09%)
since 10/19/17
52-Week
4.31 +80.28%
on 11/02/17
18.64 -58.32%
on 01/23/17
-10.28 (-56.95%)
since 01/19/17

Most Recent Stories

More News
Depomed Announces Closing of NUCYNTA Commercialization Agreement With Collegium Pharmaceutical

Depomed, Inc. (Nasdaq:DEPO) today announced the closing of its previously disclosed Commercialization Agreement ("Agreement") for the U.S. rights to commercialize both NUCYNTA(R) Extended Release and NUCYNTA(R)...

DEPO : 7.77 (-0.26%)
Shares of Intersect Ent In Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (XENT, DEPO, IPXL, RVNC, ENDP)

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

ENDP : 7.11 (-3.27%)
IPXL : 20.15 (-1.95%)
XENT : 34.55 (+1.62%)
DEPO : 7.77 (-0.26%)
RVNC : 33.95 (+0.59%)
Depomed Inc Up 39.4% Since SmarTrend Uptrend Call (DEPO)

SmarTrend identified an Uptrend for Depomed Inc (NASDAQ:DEPO) on November 10th, 2017 at $6.22. In approximately 2 months, Depomed Inc has returned 39.39% as of today's recent price of $8.67.

DEPO : 7.77 (-0.26%)
Depomed Inc Up 39.1% Since SmarTrend Uptrend Call (DEPO)

SmarTrend identified an Uptrend for Depomed Inc (NASDAQ:DEPO) on November 10th, 2017 at $6.22. In approximately 1 month, Depomed Inc has returned 39.07% as of today's recent price of $8.65.

DEPO : 7.77 (-0.26%)
New Partnership for the Commercialization of Nucynta® in the U.S. Territory

The Grünenthal Group announced today that Nucynta® (tapentadol) will be commercialized in the U.S. territory by Collegium Pharmaceutical, Inc., instead of Depomed, Inc., from 2018 onwards.

DEPO : 7.77 (-0.26%)
Depomed Announces NUCYNTA(R) Commercialization Agreement with Collegium Pharmaceutical

- Transaction is Immediately Accretive and Improves 2018 EBITDA Outlook -

DEPO : 7.77 (-0.26%)
Consolidated Research: 2018 Summary Expectations for Hanesbrands, Kinder Morgan, Groupon, Ocean Power Technologies, Depomed, and Finisar -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Hanesbrands Inc. (NYSE:HBI),...

OPTT : 1.12 (+0.90%)
KMI : 19.01 (unch)
FNSR : 20.68 (+1.27%)
GRPN : 5.57 (+9.00%)
HBI : 23.20 (+5.45%)
DEPO : 7.77 (-0.26%)
Pre-Market Technical Recap on Drug Makers Stocks -- Synergy Pharma, Novo Nordisk, United Therapeutics, and Depomed

If you want a Stock Review on SGYP, NVO, UTHR, or DEPO then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. DailyStockTracker.com redirects investors' attention...

NVO : 57.79 (+2.27%)
SGYP : 2.40 (+5.73%)
UTHR : 139.51 (-0.01%)
DEPO : 7.77 (-0.26%)
Depomed Announces Third Quarter 2017 Financial Results

- Third Quarter Net Sales of $95 Million-

DEPO : 7.77 (-0.26%)
Depomed and Slan Medicinal Holdings Ltd Announce Strategic Asset Transactions

-Depomed to Acquire Cosyntropin Depot from Slan Medicinal Holdings Limited Creating New Specialty Pharmaceutical Business -

DEPO : 7.77 (-0.26%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More

Business Summary

Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs. AcuForm-based products are designed to provide once- daily administration and reduced side effects,...

See More

Key Turning Points

2nd Resistance Point 8.01
1st Resistance Point 7.89
Last Price 7.77
1st Support Level 7.64
2nd Support Level 7.52

See More

52-Week High 18.64
Fibonacci 61.8% 13.17
Fibonacci 50% 11.47
Fibonacci 38.2% 9.78
Last Price 7.77
52-Week Low 4.31

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.